The Cambridge Molecular Therapeutics Programme, based in the Hutchison-MRC Research Centre is an interdisciplinary initiative that aims to explore new scientific paradigms for the discovery and development of small molecule therapeutics
Recent highlights include
- Collaborations between the Departments of Chemistry and Biochemistry screening compounds that disrupt quorum sensing behaviour in organisms such as P.aeruginosa
- Work in the Department of Medicine screening therapeutics for HIV.
- Work in the Department of Pathology developing for vaccines for poultry (primarily viral vaccines for chickens) and experimental vaccines for Devil Facial Tumour Disease (a transmissible tumour of Tasmanian devils)
- Research in the Department of Veterinary Medicine in the development of vaccines against respiratory diseases in swine and poultry
- Work in the Department of Pharmacology to disrupt the mechanism of multidrug transporters.
People specializing in this area
Epidemiology of vaccine preventable infections, mathematical modelling to predict and compare the impact of different immunisation strategies.